Authors' reply to: Could statins be a real therapeutic option for the treatment of hepatitis C?

被引：0
|
作者：
Malaguarnera, Michele [2 ]
Vacante, Marco [1 ]
Giordano, Maria [1 ]
Malaguarnera, Mariano [1 ]
Galvano, Fabio [2 ]
Volti, Giovanni Li [2 ]
机构：
[1] Univ Catania, Dept Internal Med & Syst Dis, Catania, Italy
[2] Univ Catania, Dept Biochem Med Chem & Mol Biol, Catania, Italy
来源：
HEPATITIS MONTHLY | 2011年 / 11卷 / 07期
关键词：
Hepatitis C; NAFLD; Ribavirin; Interferon; FATTY LIVER-DISEASE; PEGYLATED INTERFERON; RIBAVIRIN; ALPHA; FLUVASTATIN; EFFICACY;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：563 / 564
页数：2
相关论文
共 50 条
  • [1] Could statins be a real therapeutic option for the treatment of hepatitis C?
    Mendez-Navarro, Jorge
    Avelar-Escobar, Giovanni
    Gallardo-Cabrera, Victor E.
    HEPATITIS MONTHLY, 2011, 11 (07) : 562 - 563
  • [2] Are statins a viable option for the treatment of infections with the hepatitis C virus?
    Verpaalen, Ben
    Neyts, Johan
    Delang, Leen
    ANTIVIRAL RESEARCH, 2014, 105 : 92 - 99
  • [3] Could statins be a new therapeutic option for antiphospholipid syndrome patients?
    Erkan, Doruk
    Pierangeli, Silvia S.
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 115 - 117
  • [4] Treatment of chronic hepatitis C: Another therapeutic option
    Trepo, C
    Bailly, F
    Bizollon, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 62 - 64
  • [5] Towards predicting the therapeutic response in patients with hepatitis C: authors' reply
    Angelico, F.
    Del Ben, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (02) : 340 - 341
  • [6] Statins in the Treatment of Hepatitis C
    Vere, Cristin Constantin
    Streba, Costin Teodor
    Streba, Liliana
    Rogoveanu, Ion
    HEPATITIS MONTHLY, 2012, 12 (06) : 369 - 371
  • [7] Interferon-α in Hepatitis C: The Authors’ Reply
    Andrew Briggs
    Alan Shiell
    PharmacoEconomics, 1997, 11 (5) : 491 - 492
  • [8] Anti TNF-α therapy can be a novel treatment option in patients with autoimmune hepatitis: authors' reply
    Yeoman, A. D.
    Heneghan, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (01) : 116 - 117
  • [9] SCREENING FOR HEPATITIS C Authors' reply to Foster and colleagues
    Koretz, Ronald L.
    Lin, Kenneth W.
    Ioannidis, John P. A.
    Lenzer, Jeanne
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [10] Hepatitis C Antisense Nucleotide as a new Therapeutic Option
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (12): : 1356 - 1357
12345